1. Home
  2. LSTR vs RGEN Comparison

LSTR vs RGEN Comparison

Compare LSTR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landstar System Inc.

LSTR

Landstar System Inc.

HOLD

Current Price

$177.21

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$166.17

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSTR
RGEN
Founded
1988
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
LSTR
RGEN
Price
$177.21
$166.17
Analyst Decision
Hold
Buy
Analyst Count
12
12
Target Price
$173.83
$167.67
AVG Volume (30 Days)
519.1K
1.3M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
286.96
EPS
1.16
0.24
Revenue
$4,743,760,000.00
$141,236,000.00
Revenue This Year
$6.89
$14.30
Revenue Next Year
$9.05
$14.52
P/E Ratio
$154.07
$680.76
Revenue Growth
N/A
35.10
52 Week Low
$119.40
$100.99
52 Week High
$228.46
$175.77

Technical Indicators

Market Signals
Indicator
LSTR
RGEN
Relative Strength Index (RSI) 36.00 70.80
Support Level $175.06 $156.65
Resistance Level $195.84 $173.10
Average True Range (ATR) 6.92 7.76
MACD -0.83 2.31
Stochastic Oscillator 21.14 99.68

Price Performance

Historical Comparison
LSTR
RGEN

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: